Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer

CompletedOBSERVATIONAL
Enrollment

332

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

June 29, 2024

Study Completion Date

July 18, 2024

Conditions
Acute Leukemia
Interventions
DIAGNOSTIC_TEST

IUO Acute Leukemia Panel

This Investigational Panel , comprised of 6 reagents , is intended for in vitro diagnostic use for qualitative flow-cytometric immunophenotyping of immature hematopoietic cell populations. These reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having, or suspected of having, B-cell acute lymphoblastic leukemia or acute myeloid leukemia.

Trial Locations (8)

10065

New York-Presbyterian Hospital Weill Cornell Medicine, New York

27514

University Of North Carolina, Chapel Hill

37007

University of Salamanca, Salamanca

78229

CorePath Laboratories, San Antonio

90027

Childrens Hospital Los Angeles, Los Angeles

01323--020

Fleury Group, São Paulo

Unknown

Motol University Hospital, Childhood Leukemia Investigation, Prague

CB2 0QQ

Cambridge University, Cambridge

Sponsors
All Listed Sponsors
lead

Becton, Dickinson and Company

INDUSTRY